Abstract:(1) Infections following invasive endoscopy are rare and are usually of endogenous origin. Nevertheless, infections do occur due to inadequate cleaning and disinfection and the use of contaminated rinse water and processing equipment. (2) Rigid and flexible operative endoscopes and accessories should be thoroughly cleaned and preferably sterilized using properly validated processes. (3) Heat tolerant operative endoscopes and accessories should be sterilized using a vacuum assisted steam sterilizer. Use autoclavable instrument trays or containers to protect equipment during transit and processing. Small bench top sterilizers without vacuum assisted air removal are unsuitable for packaged and lumened devices. (4) Heat sensitive rigid and flexible endoscopes and accessories should preferably be sterilized using ethylene oxide, low temperature steam and formaldehyde (rigid only) or gas plasma (if appropriate). (5) If there are insufficient instruments or time to sterilize invasive endoscopes, or if no suitable method is available locally, they may be disinfected by immersion in 2% glutaraldehyde or a suitable alternative. An immersion time of at least 10 min should be adopted for glutaraldehyde. This is sufficient to inactivate most vegetative bacteria and viruses including HIV and hepatitis B virus (HBV). Longer contact times of 20 min or more may be necessary if a mycobacterial infection is known or suspected. At least 3 h immersion in glutaraldehyde is required to kill spores. (6) Glutaraldehyde is irritant and sensitizing to the skin, eyes and respiratory tract. Measures must be taken to ensure glutaraldehyde is used in a safe manner, i.e., total containment and/or extraction of harmful vapour and the provision of suitable personal protective equipment, i.e., gloves, apron and eye protection if splashing could occur. Health surveillance of staff is recommended and should include a pre-employment enquiry regarding asthma, skin and mucosal sensitivity problems and lung function testing by spirometry. (7) Possible alternative disinfectants to glutaraldehyde include peracetic acid (0.2-0.35%), chlorine dioxide (700-1100 ppm) and superoxidized water. These are very effective, killing vegetative bacteria, including mycobacteria, and viruses in 5 min and bacterial spores in 10 min. An endorsement of compatibility with endoscopes, accessories and processing equipment is required from both the solution/device manufacturer and the endoscope manufacturer. Other important considerations are stability, cost and safety from the user and environmental standpoints. (8) Cleaning and disinfection or sterilization should be undertaken by trained staff in a dedicated area, e.g., SSD or TSSU. A suitable training programme is described. (9) If endoscopes are processed by immersion in disinfectants, harmful residues must be removed by thorough rinsing. Sterile or bacteria free water is essential for rinsing all invasive endoscopes and accessories to prevent recontamination. (10) If an automated washer disinfector is used it must be effective, non-damaging, reliable, easy to use and its performance regularly monitored. (11) If used, washer disinfectors and other processing equipment should be disinfected on a regular basis, i.e., between patients or at the start of each session. This will prevent biofilm formation and recontamination of instruments during rinsing. Disinfection should include the water treatment system, if present. (12) To comply with the Medical Devices Directive, manufacturers are obliged to provide full details on how to decontaminate the reusable devices they supply. This should include details of compatibility with heat, pressure, moisture, processing chemicals and ultrasonics. (13) The Infection Control Team should always be involved in the formulation and implementation of decontamination policies. Wherever possible, the national good practice guidelines produced by the Medical Devices Agency and/or professional societies shoul

Decontamination technologies for release from bioprocessing facilities. Part I. introduction. Part II. Decontamination of wastewater

Radiation and Ethylene Oxide Terminal Sterilization Experiences with Drug Eluting Stent Products

Plasma Decontamination: A Case Study on Kill Efficacy of Geobacillus stearothermophilus Spores on Different Carrier Materials

Non‐thermal plasma decontamination of microbes: a state of the art

Elimination of antibiotic resistance genes and control of horizontal transfer risk by UV-based treatment of drinking water: A mini review

Sterilization and Disinfection of Biomaterials for Medical Devices

Contaminants of Emerging Concern Removal by High-Energy Oxidation-Reduction Processes: State of the Art

Performance evaluation for the inactivation of multidrug-resistant bacteria in wastewater effluent by different disinfection technologies

From Conventional Disinfection to Antibiotic Resistance Control—Status of the Use of Chlorine and UV Irradiation during Wastewater Treatment

Dry Bio-Decontamination Process in Reduced-Pressure O2 Plasma

Engineered Radiation-Resistant Bacteria and Their Application in Bioremediation of Radioactive Wastes-Contaminated Environment

Degradation of organic compounds and production of activated species in Dielectric Barrier Discharges and Glidarc reactors

Microbial Decontamination Of Food By Non-Thermal Plasmas

Decontamination of minimally invasive surgical endoscopes and accessories

Disinfection of swine wastewater using chlorine, ultraviolet light and ozone.

Genetically engineered bacteria for the degradation of dye and other organic compounds

Advanced Technology for Energy, Plant Nutrients and Water Recovery at Wastewater Treatment Plants

Ozone Decontamination of Medical and Nonmedical Devices: An Assessment of Design and Implementation Considerations

Plasma-Functionalized Liquids for Decontamination of Viable Tissues: A Comparative Approach

Continuous surface and air decontamination technologies: Current concepts and controversies

Multifactorial resistance of Bacillus subtilis spores to low-pressure plasma sterilization